Vestmark Advisory Solutions, Inc. Bei Gene, Ltd. Transaction History

Vestmark Advisory Solutions, Inc.

$2.21 Billion
Q2 2024

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 3,005 shares of BGNE stock, worth $674,652. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,005

Previous 3,089 2.72%

Holding current value

$674,652

Previous $483,000 11.39%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$129.52 - $174.32 $10,879 - $14,642	-84 Reduced 2.72%	3,005 $428,000
Q1 2024 May 15, 2024	BUY	$141.8 - $181.47 $210,998 - $270,027	1,488 Added 92.94%	3,089 $483,000
Q4 2023 Feb 06, 2024	BUY	$158.67 - $201.58 $22,055 - $28,019	139 Added 9.51%	1,601 $288,000
Q3 2023 Nov 06, 2023	SELL	$179.87 - $225.13 $330,960 - $414,239	-1,840 Reduced 55.72%	1,462 $262,000
Q2 2023 Aug 07, 2023	SELL	$178.3 - $266.78 $10,876 - $16,273	-61 Reduced 1.81%	3,302 $588,000
Q1 2023 May 09, 2023	SELL	$215.53 - $274.5 $9,698 - $12,352	-45 Reduced 1.32%	3,363 $724,000
Q4 2022 Jan 20, 2023	BUY	$125.51 - $229.3 $169,438 - $309,555	1,350 Added 65.6%	3,408 $0
Q3 2022 Nov 03, 2022	SELL	$131.8 - $202.24 $128,636 - $197,386	-976 Reduced 32.17%	2,058 $277,000
Q2 2022 Aug 04, 2022	BUY	$121.11 - $216.05 $161,681 - $288,426	1,335 Added 78.58%	3,034 $491,000
Q1 2022 Apr 27, 2022	BUY	$146.52 - $269.56 $53,040 - $97,580	362 Added 27.08%	1,699 $320,000
Q4 2021 Jan 31, 2022	SELL	$248.56 - $389.34 $8,948 - $14,016	-36 Reduced 2.62%	1,337 $362,000
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $20,467 - $33,057	82 Added 6.35%	1,373 $498,000
Q2 2021 Aug 09, 2021	BUY	$292.75 - $367.01 $28,689 - $35,966	98 Added 8.21%	1,291 $443,000
Q1 2021 May 10, 2021	BUY	$260.64 - $382.12 $107,383 - $157,433	412 Added 52.75%	1,193 $415,000
Q4 2020 Feb 04, 2021	BUY	$221.31 - $316.61 $15,491 - $22,162	70 Added 9.85%	781 $202,000
Q3 2020 Oct 19, 2020	BUY	$189.18 - $286.44 $134,506 - $203,658	711 New	711 $204,000

Others Institutions Holding BGNE

# of Institutions

212

Shares Held

45.1M

Call Options Held

106K

Put Options Held

93.1K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Bei Gene, Ltd. Transaction History